Health Trials

Healthy Male Participants

2

Review clinical trials related to Healthy Male Participants. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

The main purpose of this study is to determine the effect of vimseltinib on pharmacokinetics of P-glycoprotein (P-gp) substrate (dabigatran) in healthy male participants. This study will last approximately 21 days.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: Deciphera Pharmaceuticals, LLCUpdated: Aug 4, 2026
Eligibility criteria

Participants are in good general health, as required by the protocol and as dete... [+2]

History or presence of clinically significant diseases of the neurological, derm... [+2]

Read more
Status: Recruiting

A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers

This phase I study is to compare the pharmacokinetics (PK), immunogenicity, safety, and tolerability of Bmab3000 (test) and Herceptin Hylecta (reference) after a single subcutaneous (s.c.) dose in healthy male volunteers.

Participants needed: 150
Trial details
Phase: Phase 1Age: 18-65Biological sex: MaleType: InterventionalSponsor: Biocon Biologics UK PLCUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

Healthy male volunteers aged between 18 to 65 years; both inclusive. [+7]

History of previous exposure to trastuzumab. [+9]

Read more